Shopping Cart 0
Cart Subtotal
AED 0

Aequus Pharmaceuticals Inc (AQS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 918

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
AED 1835

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 2753

Details

Summary

Aequus Pharmaceuticals Inc (Aequus Pharmaceuticals) is a drug discovery and development company that develops differentiated drugs. The company's pipeline products include AQS301, AQS302 and AQS303. Its commercial pipeline comprises ophthalmology products and transplant products. Aequus Pharmaceuticals develops products in the areas of neurology and psychiatry with addressing the need for improved medication through enhanced delivery systems. The company offers its products to hospital specialty markets including patented products, branded generics, and reformulated novel-delivery products within focused therapeutic areas across Canada. It offers its products in therapeutic areas such as ophthalmology, neurology, and transplant. Aequus Pharmaceuticals is headquartered in Vancouver, British Columbia, Canada.

Aequus Pharmaceuticals Inc (AQS)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Aequus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Aequus Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Aequus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Aequus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

Aequus Pharmaceuticals Inc, Medical Devices Deals, 2012 to YTD 2018 10

Aequus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

Aequus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deal Details 13

Venture Financing 13

Aequus Pharma Raises USD0.6 Million in Venture Financing 13

Aequus Pharma Raises USD 1.2 Million In First Round Of Venture Financing 14

Partnerships 15

Aequus Pharma Enters into Agreement with Ehave 15

CannaRoyalty and Aequus Pharma Enter into Agreement 16

Aequus Pharma to Enter into Agreement with Scientus Pharma 17

Aequus Pharma Enters into Agreement with Santen 18

Aequus Pharma and Centre for Drug Research and Development Enter into a Research Agreement 19

Aequus Pharma Enters into Co-Development Agreement with Corium International 20

Aequus Pharma Enters into Co-Development Agreement with Corium International 21

Licensing Agreements 22

Aequus Pharma to Enter into Licensing Agreement with Transdermal Research Pharm Labs 22

Aequus Pharma Enters into Licensing Agreement with Supernus Pharma 23

Aequus Pharma Enters Into Licensing Agreement With Transdermal Research Pharm Labs For Transdermal Delivery Of Aripiprazole 24

Equity Offering 25

Aequus Pharma Raises USD0.2 Million in Private Placement of Units 25

Aequus Pharma Raises USD0.6 Million in Private Placement of Units 26

Aequus Raises USD0.2 Million in Private Placement of Units 28

Aequus Pharma Plans to Raise up to USD15.7 Million in Public Offering 29

Aequus Pharma Raises USD3.9 Million in Public Offering of Units 30

Aequus Pharma Raises USD2 Million in Public Offering of Shares 32

Aequus Pharma Raises USD1.3 Million in Public Offering of Shares 33

Aequus Pharma Raises USD0.6 Million in Private Placement of Shares 34

Aequus Pharma Raises USD1 Million in Public Offering of Shares 35

Aequus Pharma Raises USD3.3 Million in Private Placement of Warrants 36

Aequus Pharma Raises USD0.4 Million in Private Placement of Warrants 37

Acquisition 38

Aequus Pharma Acquires TeOra Health 38

Aequus Pharmaceuticals Inc-Key Competitors 39

Aequus Pharmaceuticals Inc-Key Employees 40

Aequus Pharmaceuticals Inc-Locations And Subsidiaries 41

Head Office 41

Other Locations & Subsidiaries 41

Recent Developments 42

Financial Announcements 42

May 31, 2018: Aequus Provides First Quarter 2018 Financial and Corporate Highlights 42

Apr 27, 2018: Aequus Pharmaceuticals Reports Fourth Quarter and Fiscal 2017 Financial Highlights 44

Nov 29, 2017: Aequus Provides Third Quarter 2017 Operational Highlights 47

Aug 29, 2017: Aequus Provides Second Quarter 2017 Operational Highlights 49

May 30, 2017: Aequus Provides First Quarter 2017 Financial Highlights 51

May 01, 2017: Aequus Provides Fourth Quarter and Fiscal 2016 Financial Highlights 52

Product News 54

09/07/2017: Aequus Announces Positive Results for Proof of Concept Clinical Trial of Anti-Nausea Patch 54

04/03/2017: Aequus Announces Positive Results from Second Proof of Concept Study for Long-Acting Aripiprazole Transdermal Patch 55

02/01/2017: Aequus Receives Non-Dilutive Funding from the Government of Canada to Support Aripiprazole Patch Development 56

Product Approvals 57

Mar 07, 2018: FDA Confirms Date to Providing Regulatory Guidance for Aequus' Anti-Nausea Patch 57

Jan 31, 2018: Aequus and Camargo Prepare for Meeting with FDA to Advance Anti-Nausea Patch 58

Aug 24, 2017: Aequus Announces Abbreviated Development Path for Transdermal Aripiprazole 59

Jun 15, 2017: Aequus Advances Clinical Development of Transdermal Anti-Nausea Patch 60

Jan 09, 2017: Aequus Initiates Second Proof of Concept Clinical Trial of Transdermal Aripiprazole Patch 61

Clinical Trials 62

Jul 05, 2017: Aequus Receives Approval from Health Canada to Initiate Proof of Concept Clinical Trial of Anti-Nausea Patch 62

Feb 14, 2017: Aequus Successfully Completes Dosing in Second Proof of Concept Clinical Trial of Transdermal Aripiprazole Patch 63

Appendix 64

Methodology 64

About GlobalData 64

Contact Us 64

Disclaimer 64


List Of Figure

List of Figures

Aequus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Aequus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Aequus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Aequus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Aequus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Aequus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7

Aequus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Aequus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

Aequus Pharmaceuticals Inc, Medical Devices Deals, 2012 to YTD 2018 10


List Of Table

List of Tables

Aequus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2

Aequus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Aequus Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Aequus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Aequus Pharmaceuticals Inc, Deals By Therapy Area, 2012 to YTD 2018 9

Aequus Pharmaceuticals Inc, Medical Devices Deals, 2012 to YTD 2018 10

Aequus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

Aequus Pharma Raises USD0.6 Million in Venture Financing 13

Aequus Pharma Raises USD 1.2 Million In First Round Of Venture Financing 14

Aequus Pharma Enters into Agreement with Ehave 15

CannaRoyalty and Aequus Pharma Enter into Agreement 16

Aequus Pharma to Enter into Agreement with Scientus Pharma 17

Aequus Pharma Enters into Agreement with Santen 18

Aequus Pharma and Centre for Drug Research and Development Enter into a Research Agreement 19

Aequus Pharma Enters into Co-Development Agreement with Corium International 20

Aequus Pharma Enters into Co-Development Agreement with Corium International 21

Aequus Pharma to Enter into Licensing Agreement with Transdermal Research Pharm Labs 22

Aequus Pharma Enters into Licensing Agreement with Supernus Pharma 23

Aequus Pharma Enters Into Licensing Agreement With Transdermal Research Pharm Labs For Transdermal Delivery Of Aripiprazole 24

Aequus Pharma Raises USD0.2 Million in Private Placement of Units 25

Aequus Pharma Raises USD0.6 Million in Private Placement of Units 26

Aequus Raises USD0.2 Million in Private Placement of Units 28

Aequus Pharma Plans to Raise up to USD15.7 Million in Public Offering 29

Aequus Pharma Raises USD3.9 Million in Public Offering of Units 30

Aequus Pharma Raises USD2 Million in Public Offering of Shares 32

Aequus Pharma Raises USD1.3 Million in Public Offering of Shares 33

Aequus Pharma Raises USD0.6 Million in Private Placement of Shares 34

Aequus Pharma Raises USD1 Million in Public Offering of Shares 35

Aequus Pharma Raises USD3.3 Million in Private Placement of Warrants 36

Aequus Pharma Raises USD0.4 Million in Private Placement of Warrants 37

Aequus Pharma Acquires TeOra Health 38

Aequus Pharmaceuticals Inc, Key Competitors 39

Aequus Pharmaceuticals Inc, Key Employees 40

Aequus Pharmaceuticals Inc, Subsidiaries 41

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

Aequus Pharmaceuticals Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Company Profile

Company Profile Title

Summary

Aequus Pharmaceuticals Inc (Aequus Pharmaceuticals) is a drug discovery and development company that develops differentiated drugs. The company's pipeline products include AQS301, AQS302 and AQS303. Its commercial pipeline comprises ophthalmology products and transplant products. Aequus Pharmaceuticals develops products in the areas of neurology and psychiatry with addressing the need for improved medication through enhanced delivery systems. The company offers its products to hospital specialty markets including patented products, branded generics, and reformulated novel-delivery products within focused therapeutic areas across Canada. It offers its products in therapeutic areas such as ophthalmology, neurology, and transplant. Aequus Pharmaceuticals is headquartered in Vancouver, British Columbia, Canada.

Aequus Pharmaceuticals Inc (AQS)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Aequus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Aequus Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Aequus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Aequus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

Aequus Pharmaceuticals Inc, Medical Devices Deals, 2012 to YTD 2018 10

Aequus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

Aequus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deal Details 13

Venture Financing 13

Aequus Pharma Raises USD0.6 Million in Venture Financing 13

Aequus Pharma Raises USD 1.2 Million In First Round Of Venture Financing 14

Partnerships 15

Aequus Pharma Enters into Agreement with Ehave 15

CannaRoyalty and Aequus Pharma Enter into Agreement 16

Aequus Pharma to Enter into Agreement with Scientus Pharma 17

Aequus Pharma Enters into Agreement with Santen 18

Aequus Pharma and Centre for Drug Research and Development Enter into a Research Agreement 19

Aequus Pharma Enters into Co-Development Agreement with Corium International 20

Aequus Pharma Enters into Co-Development Agreement with Corium International 21

Licensing Agreements 22

Aequus Pharma to Enter into Licensing Agreement with Transdermal Research Pharm Labs 22

Aequus Pharma Enters into Licensing Agreement with Supernus Pharma 23

Aequus Pharma Enters Into Licensing Agreement With Transdermal Research Pharm Labs For Transdermal Delivery Of Aripiprazole 24

Equity Offering 25

Aequus Pharma Raises USD0.2 Million in Private Placement of Units 25

Aequus Pharma Raises USD0.6 Million in Private Placement of Units 26

Aequus Raises USD0.2 Million in Private Placement of Units 28

Aequus Pharma Plans to Raise up to USD15.7 Million in Public Offering 29

Aequus Pharma Raises USD3.9 Million in Public Offering of Units 30

Aequus Pharma Raises USD2 Million in Public Offering of Shares 32

Aequus Pharma Raises USD1.3 Million in Public Offering of Shares 33

Aequus Pharma Raises USD0.6 Million in Private Placement of Shares 34

Aequus Pharma Raises USD1 Million in Public Offering of Shares 35

Aequus Pharma Raises USD3.3 Million in Private Placement of Warrants 36

Aequus Pharma Raises USD0.4 Million in Private Placement of Warrants 37

Acquisition 38

Aequus Pharma Acquires TeOra Health 38

Aequus Pharmaceuticals Inc-Key Competitors 39

Aequus Pharmaceuticals Inc-Key Employees 40

Aequus Pharmaceuticals Inc-Locations And Subsidiaries 41

Head Office 41

Other Locations & Subsidiaries 41

Recent Developments 42

Financial Announcements 42

May 31, 2018: Aequus Provides First Quarter 2018 Financial and Corporate Highlights 42

Apr 27, 2018: Aequus Pharmaceuticals Reports Fourth Quarter and Fiscal 2017 Financial Highlights 44

Nov 29, 2017: Aequus Provides Third Quarter 2017 Operational Highlights 47

Aug 29, 2017: Aequus Provides Second Quarter 2017 Operational Highlights 49

May 30, 2017: Aequus Provides First Quarter 2017 Financial Highlights 51

May 01, 2017: Aequus Provides Fourth Quarter and Fiscal 2016 Financial Highlights 52

Product News 54

09/07/2017: Aequus Announces Positive Results for Proof of Concept Clinical Trial of Anti-Nausea Patch 54

04/03/2017: Aequus Announces Positive Results from Second Proof of Concept Study for Long-Acting Aripiprazole Transdermal Patch 55

02/01/2017: Aequus Receives Non-Dilutive Funding from the Government of Canada to Support Aripiprazole Patch Development 56

Product Approvals 57

Mar 07, 2018: FDA Confirms Date to Providing Regulatory Guidance for Aequus' Anti-Nausea Patch 57

Jan 31, 2018: Aequus and Camargo Prepare for Meeting with FDA to Advance Anti-Nausea Patch 58

Aug 24, 2017: Aequus Announces Abbreviated Development Path for Transdermal Aripiprazole 59

Jun 15, 2017: Aequus Advances Clinical Development of Transdermal Anti-Nausea Patch 60

Jan 09, 2017: Aequus Initiates Second Proof of Concept Clinical Trial of Transdermal Aripiprazole Patch 61

Clinical Trials 62

Jul 05, 2017: Aequus Receives Approval from Health Canada to Initiate Proof of Concept Clinical Trial of Anti-Nausea Patch 62

Feb 14, 2017: Aequus Successfully Completes Dosing in Second Proof of Concept Clinical Trial of Transdermal Aripiprazole Patch 63

Appendix 64

Methodology 64

About GlobalData 64

Contact Us 64

Disclaimer 64


List Of Figure

List of Figures

Aequus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Aequus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Aequus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Aequus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Aequus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Aequus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7

Aequus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Aequus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

Aequus Pharmaceuticals Inc, Medical Devices Deals, 2012 to YTD 2018 10


List Of Table

List of Tables

Aequus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2

Aequus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Aequus Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Aequus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Aequus Pharmaceuticals Inc, Deals By Therapy Area, 2012 to YTD 2018 9

Aequus Pharmaceuticals Inc, Medical Devices Deals, 2012 to YTD 2018 10

Aequus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

Aequus Pharma Raises USD0.6 Million in Venture Financing 13

Aequus Pharma Raises USD 1.2 Million In First Round Of Venture Financing 14

Aequus Pharma Enters into Agreement with Ehave 15

CannaRoyalty and Aequus Pharma Enter into Agreement 16

Aequus Pharma to Enter into Agreement with Scientus Pharma 17

Aequus Pharma Enters into Agreement with Santen 18

Aequus Pharma and Centre for Drug Research and Development Enter into a Research Agreement 19

Aequus Pharma Enters into Co-Development Agreement with Corium International 20

Aequus Pharma Enters into Co-Development Agreement with Corium International 21

Aequus Pharma to Enter into Licensing Agreement with Transdermal Research Pharm Labs 22

Aequus Pharma Enters into Licensing Agreement with Supernus Pharma 23

Aequus Pharma Enters Into Licensing Agreement With Transdermal Research Pharm Labs For Transdermal Delivery Of Aripiprazole 24

Aequus Pharma Raises USD0.2 Million in Private Placement of Units 25

Aequus Pharma Raises USD0.6 Million in Private Placement of Units 26

Aequus Raises USD0.2 Million in Private Placement of Units 28

Aequus Pharma Plans to Raise up to USD15.7 Million in Public Offering 29

Aequus Pharma Raises USD3.9 Million in Public Offering of Units 30

Aequus Pharma Raises USD2 Million in Public Offering of Shares 32

Aequus Pharma Raises USD1.3 Million in Public Offering of Shares 33

Aequus Pharma Raises USD0.6 Million in Private Placement of Shares 34

Aequus Pharma Raises USD1 Million in Public Offering of Shares 35

Aequus Pharma Raises USD3.3 Million in Private Placement of Warrants 36

Aequus Pharma Raises USD0.4 Million in Private Placement of Warrants 37

Aequus Pharma Acquires TeOra Health 38

Aequus Pharmaceuticals Inc, Key Competitors 39

Aequus Pharmaceuticals Inc, Key Employees 40

Aequus Pharmaceuticals Inc, Subsidiaries 41

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

Aequus Pharmaceuticals Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.